Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Portal Hypertension: later-stage trial registry
3 of 10 indexed Portal Hypertension trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 3 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Portal Hypertension: 10 US clinical trials tracked, 3 recruiting.
Portal Hypertension is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Michigan, running 2 of these trials.
Enrollment posture brief
Registry condition portal-hypertension
OPEN 3 | RECR 30% | LATE 4 | EARLY 1 | RANK #1724 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adrenocortical Carcinoma (30% recruiting · 10 trials)
Portal Hypertension lists 3 open slots (30% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Portal Hypertension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Portal Hypertension is recruiting below its size-band peers.
3 of 10 indexed trials (30%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Portal Hypertension research.
University of Michigan accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.
-
Most Portal Hypertension trials plan to enrol fewer than 100 people.
Median target enrolment is 70 among the 10 trials that report a genuine target (sentinel values excluded). 6 of those (60%) plan for fewer than 100 participants.
-
Portal Hypertension research is mostly interventional.
8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Thomas Jefferson University
NCT05470205
Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension
Mayo Clinic
NCT06797193
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Massachusetts General Hospital
NCT06265272
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study
University of Michigan
NCT07140120
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
Davendra Sohal
NCT05027425
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
VA Connecticut Healthcare System
NCT01644656
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
University of Michigan
NCT05794555
Prevention of Esophageal Varices by Beta-Adrenergic Blockers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00006398
Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
Debiovision
NCT00331188
Evaluation of 3D Overlay During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure
Medical College of Wisconsin
NCT02053571
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Portal Hypertension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Portal Hypertension trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Portal Hypertension page
10 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Portal Hypertension trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Michigan sponsors the most Portal Hypertension trials on record, review their full trial history before evaluating a specific study. See University of Michigan's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Portal Hypertension condition card totals 10 registered trials; most-linked intervention Sanvar® (vapreotide); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.